On 24 August 2020, the University Council approved the appointment of two new professors to the Biozentrum of the University of Basel. Knut Drescher, currently a research group leader at the Max Planck Institute for…
The Swiss Economic Award is the most important young entrepreneur prize in Switzerland. In a multi-stage selection process, T3 Pharma has succeeded from among the 107 applicants and has been awarded the prize in the…
Precision Microbiota Engineering for Child Health The project “Precision Microbiota Engineering for Child Health”, headed by Prof. Emma Wetter Slack of the ETH Zurich, aims to modify the microbiota of individuals with inborn…
The BaseLaunch program was launched in 2017 as an initiative of BaselArea.swiss, the office for business promotion for Northwestern Switzerland, with the aim of strengthening the start-up scene in the Basel region and…
Prof. em. Werner Arber is a pioneer in molecular biological research, investigating the structure and function of DNA and the interaction of genes and proteins. With his discovery of molecular scissors for genes, the…
The neurobiologist Prof. Silvia Arber is awarded the 2017 Louis-Jeantet Prize for Medicine for her contributions to our understanding of how movement is controlled in mammals. The Louis-Jeantet Foundation grants the sum of…
With our deepest regret we announce the passing of Prof. Heinrich Reichert. Our colleague, friend and Professor emeritus of Neurobiology passed away on Thursday, 13 June 2019 after a severe illness, about two months before…
Today, the BBVA Foundation announced that Prof. Michael Hall from the Biozentrum of the University of Basel and Prof. David Sabatini from the MIT, USA, have been awarded the Frontiers of Knowledge Award in the category…
With the renowned Starting Grants, the SNSF honors excellent young researchers for their innovative research and supports them in consolidating their own research program. Yuping Li is one of the top young researchers to…
In 2012, the "European Autism Interventions - A Multicentre Study for Developing New Medications" (EU-AIMS) was launched as a collaboration for research for the treatment of autism. The aim of this collaboration is to…
This website uses cookies to collect data from users and improve functionality. By continuing to browse the site you are agreeing to this. Receive more information by reading our privacy policy.
